|
Sep 05, 2023
|
AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
|
|
|
Aug 04, 2023
|
AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
|
|
|
Jul 28, 2023
|
AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
|
|
|
Jul 26, 2023
|
AC Immune SA Appoints New Chief Medical Officer
|
|
|
Jul 03, 2023
|
AC Immune Showcasing Precision Medicine Programs at AAIC 2023
|
|
|
Jun 27, 2023
|
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease
|
|
|
Jun 23, 2023
|
AC Immune Holds Annual General Meeting of Shareholders
|
|
|
Apr 28, 2023
|
AC Immune Reports First Quarter 2023 Financial Results and Provides a Corporate Update
|
|
|
Apr 05, 2023
|
AC Immune to Host Key Opinion Leader Webinar on Early Diagnosis and Prevention of Alzheimer’s Disease
|
|
|
Mar 20, 2023
|
AC Immune at AD/PD™ 2023 to Present New Clinical and Preclinical Data from its Precision Medicine Pipeline
|
|